P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 212 500 KRW -2.97%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

296.6B
+6%
Revenue
Growth Rates:
1 Year
+34%
3 Years
+122%
5 Years
+304%
7 Years
+528%
10 Years
-
102.2B
+7%
Operating Income
Growth Rates:
1 Year
+41%
3 Years
+123%
5 Years
+795%
7 Years
+564%
10 Years
-
90.7B
+19%
Net Income
Growth Rates:
1 Year
+63%
3 Years
+118%
5 Years
+454%
7 Years
+574%
10 Years
-

Earnings Waterfall
PharmaResearch Co Ltd

Revenue
296.6B KRW
Cost of Revenue
-85.6B KRW
Gross Profit
211B KRW
Operating Expenses
-108.8B KRW
Operating Income
102.2B KRW
Other Expenses
-11.4B KRW
Net Income
90.7B KRW

Income Statement
PharmaResearch Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
24 765
N/A
28 237
+14%
31 577
+12%
34 543
+9%
37 455
+8%
40 854
+9%
43 810
+7%
45 094
+3%
45 953
+2%
46 580
+1%
47 240
+1%
50 614
+7%
54 470
+8%
56 518
+4%
60 777
+8%
61 865
+2%
64 281
+4%
70 242
+9%
73 324
+4%
77 416
+6%
83 872
+8%
84 091
+0%
91 747
+9%
101 283
+10%
108 746
+7%
122 609
+13%
133 706
+9%
143 282
+7%
154 083
+8%
164 813
+7%
175 719
+7%
183 191
+4%
194 759
+6%
204 932
+5%
222 030
+8%
244 661
+10%
261 011
+7%
280 285
+7%
296 594
+6%
Gross Profit
Cost of Revenue
(6 555)
(7 830)
(9 611)
(10 579)
(11 687)
(12 644)
(12 999)
(14 187)
(15 116)
(15 612)
(16 131)
(17 038)
(18 405)
(19 216)
(21 862)
(23 409)
(26 064)
(28 623)
(30 954)
(33 140)
(33 766)
(33 603)
(34 271)
(35 024)
(35 850)
(38 538)
(40 183)
(42 495)
(45 750)
(49 113)
(51 440)
(52 202)
(53 246)
(54 915)
(58 063)
(63 915)
(70 753)
(78 668)
(85 590)
Gross Profit
18 210
N/A
20 408
+12%
21 967
+8%
23 965
+9%
25 768
+8%
28 210
+9%
30 811
+9%
30 907
+0%
30 837
0%
30 968
+0%
31 109
+0%
33 577
+8%
36 065
+7%
37 303
+3%
38 916
+4%
38 456
-1%
38 217
-1%
41 620
+9%
42 371
+2%
44 277
+4%
50 106
+13%
50 488
+1%
57 476
+14%
66 258
+15%
72 896
+10%
84 070
+15%
93 522
+11%
100 787
+8%
108 333
+7%
115 701
+7%
124 280
+7%
130 989
+5%
141 513
+8%
150 018
+6%
163 967
+9%
180 746
+10%
190 258
+5%
201 617
+6%
211 004
+5%
Operating Income
Operating Expenses
(6 796)
(7 045)
(7 944)
(8 201)
(9 674)
(12 377)
(13 960)
(14 210)
(16 732)
(15 272)
(15 728)
(17 083)
(21 222)
(24 021)
(26 780)
(30 758)
(29 512)
(33 589)
(30 956)
(30 620)
(31 044)
(31 783)
(34 868)
(37 797)
(39 470)
(44 155)
(47 738)
(50 830)
(55 844)
(61 109)
(66 208)
(70 050)
(75 597)
(83 708)
(91 402)
(97 204)
(98 001)
(106 550)
(108 823)
Selling, General & Administrative
(4 671)
(4 817)
(5 883)
(6 252)
(7 439)
(9 862)
(10 874)
(11 369)
(12 844)
(11 302)
(10 914)
(11 366)
(16 127)
(17 283)
(20 435)
(23 398)
(21 213)
(22 809)
(21 449)
(20 827)
(20 536)
(21 379)
(24 260)
(26 711)
(28 535)
(31 034)
(33 691)
(36 760)
(42 762)
(46 882)
(51 123)
(53 941)
(59 651)
(61 367)
(67 182)
(71 841)
(75 095)
(79 359)
(80 270)
Research & Development
(1 899)
(1 624)
(1 615)
(1 569)
(1 763)
(2 013)
(2 578)
(2 309)
(3 378)
(3 447)
(4 269)
(5 150)
(4 497)
(5 206)
(4 529)
(4 379)
(4 043)
(4 177)
(4 368)
(4 824)
(5 614)
(5 569)
(5 386)
(5 673)
(5 543)
(6 167)
(6 793)
(6 581)
(6 738)
(7 002)
(7 578)
(8 305)
(8 702)
(9 706)
(11 481)
(12 506)
(15 030)
(16 189)
(17 727)
Depreciation & Amortization
(226)
(575)
(417)
(351)
(471)
(497)
(504)
(529)
(510)
(523)
(543)
(566)
(597)
(649)
(1 815)
(2 980)
(4 257)
(5 570)
(5 143)
(4 973)
(4 894)
(4 837)
(5 224)
(5 414)
(5 392)
(5 704)
(6 009)
(6 244)
(6 344)
(6 385)
(6 715)
(7 013)
(7 384)
(7 711)
(7 767)
(7 885)
(8 003)
(8 171)
(8 222)
Other Operating Expenses
0
(29)
(29)
(29)
0
(5)
(4)
(3)
0
0
0
0
0
(883)
0
0
0
(1 033)
4
4
0
0
0
0
0
(1 250)
(1 245)
(1 245)
0
(840)
(792)
(792)
140
(4 924)
(4 972)
(4 972)
128
(2 831)
(2 605)
Operating Income
11 414
N/A
13 361
+17%
14 022
+5%
15 763
+12%
16 094
+2%
15 833
-2%
16 850
+6%
16 696
-1%
14 105
-16%
15 695
+11%
15 382
-2%
16 494
+7%
14 843
-10%
13 283
-11%
12 136
-9%
7 699
-37%
8 705
+13%
8 030
-8%
11 414
+42%
13 656
+20%
19 062
+40%
18 706
-2%
22 609
+21%
28 463
+26%
33 426
+17%
39 917
+19%
45 786
+15%
49 958
+9%
52 489
+5%
54 592
+4%
58 071
+6%
60 939
+5%
65 916
+8%
66 309
+1%
72 565
+9%
83 541
+15%
92 258
+10%
95 067
+3%
102 181
+7%
Pre-Tax Income
Interest Income Expense
(304)
(330)
(453)
(132)
168
1 813
3 455
4 165
3 308
2 250
1 740
1 319
1 861
2 100
3 204
2 874
650
1 232
(1 359)
(918)
73
(154)
(81)
(866)
3 382
3 146
3 848
5 993
4 030
2 555
(2 426)
(1 314)
(6 668)
(3 937)
960
4 686
12 355
7 014
13 792
Non-Reccuring Items
(29)
0
0
0
(3)
0
0
0
0
0
0
0
(881)
0
(1 917)
(1 917)
(868)
0
0
0
67
0
(6)
(6)
(1 251)
0
0
0
(840)
0
0
0
(5 111)
0
0
0
(3 120)
0
0
Gain/Loss on Disposition of Assets
(16)
(5)
(5)
(5)
(1)
(4)
(7)
(49)
(60)
(87)
(89)
(59)
(84)
0
(187)
(396)
(495)
0
(513)
(473)
(325)
0
0
(231)
(363)
0
0
0
230
254
290
245
(114)
(88)
(127)
(83)
36
(6)
(1)
Total Other Income
25
21
(49)
(42)
(73)
(95)
(92)
(92)
(28)
(17)
(327)
(328)
(344)
(405)
(607)
(708)
6 373
5 430
6 481
6 662
(348)
(277)
4 443
4 432
4 343
4 256
(290)
88
124
22
64
2
25
71
(643)
(561)
(825)
(938)
(155)
Pre-Tax Income
11 091
N/A
13 047
+18%
13 516
+4%
15 585
+15%
16 185
+4%
17 547
+8%
20 205
+15%
20 719
+3%
17 325
-16%
17 842
+3%
16 706
-6%
17 426
+4%
15 396
-12%
14 978
-3%
12 628
-16%
7 551
-40%
14 364
+90%
14 692
+2%
16 023
+9%
18 927
+18%
18 529
-2%
18 275
-1%
26 965
+48%
31 791
+18%
39 537
+24%
47 319
+20%
49 345
+4%
56 038
+14%
56 033
0%
57 423
+2%
55 999
-2%
59 872
+7%
54 048
-10%
62 356
+15%
72 754
+17%
87 583
+20%
100 705
+15%
101 137
+0%
115 817
+15%
Net Income
Tax Provision
(2 254)
(2 633)
(2 884)
(3 277)
(3 308)
(3 553)
(3 830)
(4 056)
(3 498)
(3 613)
(3 478)
(3 219)
(2 879)
(2 795)
(2 955)
(2 840)
(3 099)
(3 285)
(2 726)
(2 697)
(3 678)
(3 604)
(5 787)
(6 579)
(7 085)
(6 697)
(6 511)
(7 152)
(9 210)
(13 088)
(13 642)
(14 193)
(10 614)
(10 446)
(15 440)
(18 683)
(23 440)
(23 895)
(25 039)
Income from Continuing Operations
8 838
10 414
10 631
12 307
12 878
13 993
16 375
16 664
13 827
14 229
13 228
14 206
12 517
12 183
9 673
4 711
11 265
11 406
13 296
16 229
14 851
14 671
21 178
25 212
32 452
40 623
42 834
48 886
46 824
44 335
42 357
45 680
43 434
51 910
57 314
68 900
77 265
77 243
90 778
Income to Minority Interest
0
0
0
0
0
0
0
60
82
149
245
317
439
397
1 463
2 203
3 143
3 904
3 087
2 831
1 817
1 736
1 930
1 790
322
(470)
(1 300)
(1 775)
(135)
(583)
9
821
(2 857)
(2 946)
(1 699)
(3 998)
(713)
(1 151)
(34)
Net Income (Common)
8 836
N/A
10 413
+18%
10 629
+2%
12 305
+16%
12 878
+5%
13 993
+9%
16 375
+17%
16 725
+2%
13 909
-17%
14 378
+3%
13 473
-6%
14 523
+8%
12 956
-11%
12 580
-3%
11 135
-11%
6 914
-38%
14 408
+108%
15 311
+6%
16 385
+7%
19 061
+16%
16 667
-13%
16 408
-2%
23 109
+41%
27 003
+17%
32 774
+21%
40 152
+23%
41 533
+3%
47 109
+13%
46 689
-1%
43 752
-6%
42 366
-3%
46 501
+10%
40 577
-13%
48 964
+21%
55 615
+14%
64 902
+17%
76 551
+18%
76 092
-1%
90 744
+19%
EPS (Diluted)
1 262.28
N/A
1 487.57
+18%
1 518.42
+2%
1 757.85
+16%
1 609.75
-8%
1 554.77
-3%
1 819.44
+17%
1 858.33
+2%
1 545.44
-17%
1 597.55
+3%
1 497
-6%
1 613.66
+8%
1 439.55
-11%
1 258
-13%
1 237.22
-2%
768.22
-38%
1 440.8
+88%
1 531.1
+6%
1 820.55
+19%
2 117.88
+16%
1 851.88
-13%
1 823.11
-2%
2 310.9
+27%
2 700.3
+17%
3 277.4
+21%
4 063.45
+24%
4 163.31
+2%
4 722.28
+13%
4 644.41
-2%
4 149.42
-11%
4 018
-3%
4 410.17
+10%
3 848.31
-13%
4 638.18
+21%
5 236.01
+13%
6 155.34
+18%
7 249.68
+18%
7 205.61
-1%
8 593.11
+19%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 198,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.